关于Candida albicans感染的最新消息:病原体,耐药性和新兴的纳米药物策略
Marilena Pariano1, Matteo Puccetti2, Consuelo Fabi1
1Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
Expert review of anti-infective therapy
|October 6, 2025
概括
疹,由疹酵母引起,呈现出各种感染. 本综述更新了关于Candida病原体,抗真菌耐药性和Candida albicans新疗法的知识,重点关注新兴策略.
科学领域:
- 医学真菌学 医学真菌学
- 传染性疾病 传染性疾病
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- кандидоз是一种由机会性酵母 Candida 引起的感染谱,Candida albicans 是最常见的物种.
- 了解Candida的发病过程涉及诸如形态可塑性,代谢灵活性,生物膜形成和肠道失调等因素.
研究的目的:
- 提供最新的病变发生,耐药性模式和候群病的新兴治疗策略的综述,特别关注Candida albicans.
- 突出最近在抗真菌耐药性,诊断和新型治疗方面的进展,包括下一代抗真菌药物,组合疗法和纳米药物.
主要方法:
- 在PubMed,Scopus和Google Scholar的文献搜索中,强调了过去五年的出版物.
- 对抗真菌耐药性趋势,诊断创新和新型治疗策略的最新发展进行审查.
- 探索新兴策略,如益生菌,疫苗和抗真菌管理,考虑到影响候群病流行病学的因素.
主要成果:
- 最近的进展加深了对Candida病变的理解,包括其形态和代谢灵活性,生物膜形成以及在肠道失调症中的作用.
- 在识别抗真菌耐药性趋势,开发创新的诊断工具和探索新的治疗途径方面取得了重大进展.
- 益生菌,疫苗和抗真菌管理等新兴策略,以及COVID-19后免疫抑制,癌症治疗和气候变化的影响,正在塑造 кандидоз流行病学.
结论:
- 未来的Candida albicans管理依赖于个性化的方法,整合基因组学和宿主-病原体相互作用.
- 先进的药物输送平台对于对抗耐药性和改善系统性候群病患者的治疗结果至关重要.
- 打击耐药性和克服当前的治疗局限性需要创新的策略,以更好地管理患者.
相关概念视频
Fungal Phylum Microsporidia
422
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
422
Gene Regulation in Microbial Communities: Quorum Sensing
518
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
518
Microorganisms in Medicine and Therapeutics
960
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
960
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


